Scorri verso il basso
August 12, 2026 October 6–7, 2026 | Palm Springs Convention Center, California
Meet Linuo at Booth 118 to discuss Prefillable Syringe requirements for biologics, vaccines, high-value injectables, and combination products.
Linuo Pharmaceutical Packaging will participate in PDA Universe of Prefillable Syringes and Injection Devices 2026, presenting its Prefillable Syringe packaging direction for injectable drug-delivery applications.
At Booth 118, the Linuo team will meet pharmaceutical companies, biopharmaceutical developers, CDMOs, aseptic filling companies and injection-device manufacturers. Discussions will focus on PFS specifications, filling-line fit, container and drug-product compatibility considerations, device integration, quality requirements and scalable supply evaluation.
A Prefillable Syringe is designed to receive the drug product before it reaches the point of administration.
Compared with a workflow that requires medicine to be withdrawn from a vial before injection, a prefilled format reduces drug-transfer and preparation steps. Predetermined-dose packaging can also reduce errors associated with manual withdrawal and support a more consistent administration process.
At PDA Universe 2026, Linuo will focus on PFS requirements related to:
The suitability of a particular PFS format must be evaluated according to the drug product, filling process, administration method and intended injection device.
Linuo will use the exhibition to support project-specific communication. The purpose is not to present one PFS configuration as suitable for every injectable drug, but to understand the customer’s requirements and identify the areas that require technical evaluation.
The discussion can begin with the intended PFS format, pharmaceutical application and current development stage.
The target container should be considered alongside the drug formulation, dose, filling process and intended method of administration.
Biologics and high-value injectable products require careful consideration of the relationship between the drug product and its primary packaging.
Relevant considerations may include:
The exact compatibility assessment, testing scope and acceptance criteria must be confirmed for each individual project.
The selected Prefillable Syringe must be evaluated in relation to the customer’s filling equipment and production workflow.
Technical discussions can cover:
The final format should be confirmed according to the intended filling equipment and manufacturing process.
Sealing performance is an important consideration in a PFS project. The syringe, closure components, filling process and intended delivery device must be reviewed as a complete system.
Customers can discuss their sealing and mechanical requirements with Linuo. The relevant testing methods and performance criteria should be defined during project-specific evaluation.
Prefillable Syringes may be used with auto-injectors, pen injectors and other combination-product systems.
Device-integration discussions include:
These requirements should be reviewed jointly by the pharmaceutical company, filling organization, packaging supplier and injection-device developer.
Linuo welcomes pharmaceutical and biopharmaceutical companies developing monoclonal antibodies, recombinant proteins, vaccines, oncology drugs, rare-disease medicines and other high-value injectable products.
These Projects may place particular emphasis on:
Linuo can discuss these requirements according to the project’s development stage, from initial container evaluation and filling-line assessment to commercial-scale supply planning.
CDMOs and aseptic filling organizations need to determine whether the selected PFS format is compatible with their equipment and manufacturing workflow.
Their principal evaluation areas may include:
At Booth 118, CDMOs and fill-finish companies can discuss their equipment, production process and intended PFS format with Linuo.
This communication can help define the technical information, samples, testing requirements and quality documentation needed before a project progresses from development to commercial production.
When a Prefillable Syringe is integrated into an auto-injector, pen injector or another delivery device, the container and device must operate as a coordinated system.Stable dimensions and clearly defined interfaces are important elements of device-integration discussions.
Linuo can participate in technical communication involving pharmaceutical developers, CDMOs and device companies so that container, filling and final drug-delivery requirements can be considered together.
A PFS project involves more than selecting a syringe format. The selected packaging must also progress through filling, quality evaluation, device integration and supply assessment.
Linuo’s support direction covers four principal stages.
The first stage is to understand the intended PFS format, application, administration method and project phase.
The customer and Linuo team can identify the main specifications and technical questions that require further discussion.
The proposed format must be evaluated in relation to the filling equipment and any intended injection device.
This stage may involve dimensions, equipment fit, interfaces, sealing requirements and mechanical performance.
Quality discussions may include dimensions, appearance, sealing, mechanical performance and the documents required for customer evaluation.
The exact testing scope, quality standards and available documents must be confirmed for each project.
As the program progresses toward commercialization, the customer may need to evaluate batch consistency, traceability and scalable supply.
Linuo can discuss the manufacturing and quality information needed to support this evaluation.
PDA Universe of Prefillable Syringes and Injection Devices 2026 will take place on October 6–7, 2026.
The event will be held at the Palm Springs Convention Center in California.
Yes. Auto-injector, pen-injector and combination-product developers can discuss dimensions, interfaces, sealing, mechanical performance and device integration.
Linuo will focus on Prefillable Syringe packaging for injectable drug delivery and combination-product applications.
Visitors can discuss target PFS formats, compatibility considerations, filling-line fit, dimensional consistency, sealing requirements, device integration, quality requirements and scalable supply evaluation.
Yes. CDMOs and aseptic filling organizations can discuss PFS specifications, equipment fit, dimensional consistency, batch quality and required documentation.
We will reply to you within 24 hours. If for urgent case, please add WhatsApp/WeChat: +8618615646416, Or call +8618615646416 directly.
*We respect your confidentiality and all information are protected.
We will only use your information to respond to your inquiry and will never send unsolicited emails or promotional messages.
